Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

被引：1
|
作者：
Al-Samkari, Hanny [1 ,2 ,9 ]
Jiang, Debbie [3 ,4 ]
Gernsheimer, Terry [3 ,4 ]
Liebman, Howard [5 ]
Lee, Susie [5 ]
Bernheisel, Chelsea
Wojdyla, Matthew [6 ]
Vredenburg, Michael [6 ]
Cuker, Adam [7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Washington, Div Hematol, Seattle, WA USA
[4] Seattle Canc Care Alliance, Seattle, WA USA
[5] Univ Southern Calif, Keck Sch Med, Hematol, Los Angeles, CA USA
[6] Sobi Inc, Durham, NC USA
[7] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[8] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[9] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2023年 / 7卷 / 03期
关键词：
avatrombopag; eltrombopag; immune thrombocytopenia; romiplostim; thrombopoietin receptor;
D O I：
10.1016/j.rpth.2023.100134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry B.
    Liebman, Howard A.
    Lee, Susie
    Bernheisel, Chelsea
    Kolodny, Scott
    Wojdyla, Matthew
    Vredenburg, Michael
    Jamieson, Brian
    Cuker, Adam
    [J]. BLOOD, 2021, 138
  • [2] Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    [J]. BLOOD, 2023, 142
  • [3] Interim Analysis of Treatment Satisfaction from a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag or Romiplostim to Avatrombopag
    Tarantino, Michael D.
    Kolodny, Scott
    Zhang, Jessica
    Jamieson, Brian
    Vredenburg, Michael
    [J]. BLOOD, 2023, 142
  • [4] Use of eltrombopag after romiplostim in primary immune thrombocytopenia
    Ramon Gonzalez-Porras, Jose
    Eva Mingot-Castellano, Maria
    Andrade, Marcio M.
    Alonso, Rafael
    Caparros, Isabel
    Carmen Arratibel, Maria
    Fernandez-Fuertes, Fernando
    Jose Cortti, Maria
    Pascual, Cristina
    Sanchez-Gonzalez, Blanca
    Bernat, Silvia
    Angel Fuertes-Palacio, Miguel
    Andres Vazquez-Paganini, Juan
    Olivera, Pavel E.
    Teresa Alvarez-Roman, Maria
    Jarque, Isidro
    Cortes, Montserrat
    Martinez-Robles, Violeta
    Javier Diaz-Galvez, Francisco
    Calbacho, Maria
    Fernandez-Minano, Carmen
    Garcia-Frade, Javier
    Jose Gonzalez-Lopez, Tomas
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 111 - 116
  • [5] Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (02) : 168 - 168
  • [6] Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients
    Khellaf, Mehdi
    Viallard, Jean-Francois
    Hamidou, Mohamed
    Cheze, Stephane
    Lefrere, Francois
    Fain, Olivier
    Audia, Sylvain
    Jardin, Fabrice
    Gyan, Emmanuel
    Durand, Jean Marc
    Haioun, Corinne
    Bierling, Philippe
    Michel, Marc
    Godeau, Bertrand
    [J]. BLOOD, 2012, 120 (21)
  • [7] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. BLOOD, 2018, 132
  • [8] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [9] Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry
    Liebman, Howard
    Lee, Susie
    Wojdyla, Matthew
    Vredenburg, Michael
    Cuker, Adam
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (03) : 359 - 366
  • [10] Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry
    Tomasello, Riccardo
    Garabet, Lamya
    Pettersen, Heidi
    Tjonnfjord, Eirik
    Tsykunova, Galina
    Pedersen, Torkild
    Tran, Hoa
    Napolitano, Mariasanta
    Ghanima, Waleed
    [J]. BLOOD, 2023, 142
12345